Healthtech
Q3 202418.07.2024

Drug discovery (Q3 2024)

Picture of Kai Nicol-Schwarz

Kai Nicol-Schwarz

at Sifted

Developing drugs is a very long and expensive process. It can take between 10 and 15 years and cost more than $1bn to bring one to market. It’s also hit and miss — with the latter doing most of the heavy lifting. 90% of drugs that make it to human trials — the final stage before approval — fail.

But increasingly startups are looking to speed up the process using new tech like proprietary machine learning algorithms and generative AI. While some are looking to develop their own drug candidates, others are building tools to be used by pharma companies and other biotechs.

For startups, there are reasons to be cheerful. AI and ML present a “huge opportunity” for tech companies to solve problems in the drug discovery space, one investor tells Sifted. Another says the approaching “patent cliff” — which will see several revenue-driving drug patents expire — is an “unprecedented opportunity” for startups as pharma companies look to bolster drug pipelines. Others say they’ve noticed lead times to sell into pharma drop since pre-Covid times.

Positive moves — but it’s still early days. While there are some AI-developed drugs in clinical trials, none have yet made it to market. With or without startups — drug discovery is a long game. Investors say major AI-driven advances in the drug discovery process will likely come in the next decade, rather than the next few years. But, if VC confidence in the sector holds, there’s every chance startups could play an increasingly key role in the sector going forward.

20 startups to watch

  • CHARM Therapeutics logo

    Sifted score

    9.13
    -

    CHARM Therapeutics

    3D deep learning for undruggable diseases.

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2021

    • HQ

      London, United Kingdom

    • Latest round

      Early VC
      €18.2m / Apr 2023

    • Total funding

      €75.1m

  • Aqemia logo

    Sifted score

    9.02
    -

    Aqemia

    • Strong investor(s)
    • Serial founder(s)
    • Hiring
    • Year founded

      2019

    • HQ

      Paris, France

    • Latest round

      Series A
      €30m / Jan 2024

    • Total funding

      €70.9m

  • Chemify logo

    Sifted score

    8.08
    -

    Chemify

    • Strong investor(s)
    • Serial founder(s)
    • Hiring
    • Year founded

      2022

    • HQ

      Glasgow, United-Kingdom

    • Latest round

      Series A
      €39.8m / Aug 2023

    • Total funding

      €39.8m

  • Abzu logo

    Sifted score

    7.98
    -

    Abzu

    Explainable AI for pharmaceutical research.

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2018

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      €2.5m / Jun 2022

    • Total funding

      €10.4m

  • Kvantify logo

    Sifted score

    7.97
    -

    Kvantify

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2022

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      €2m / Oct 2023

    • Total funding

      €9m

Related Briefings

Related articles

AI is turning finance from reactive to proactive
Artificial intelligencePaid for and produced by

October 14, 2026

AI is turning finance from reactive to proactive

AI is turning finance from reactive to proactive
Paid for and produced by Intuit QuickBooks
How I became a community manager at Lovable
Startup lifeInterview

October 14, 2026

How I became a community manager at Lovable

How I became a community manager at Lovable
By Éanna Kelly
What US Big Tech taught me about leading a startup — and what I had to unlearn

October 14, 2026

What US Big Tech taught me about leading a startup — and what I had to unlearn

What US Big Tech taught me about leading a startup — and what I had to unlearn
By Ben Chisell
‘There's never a right time to start’: Why founders don’t need a master plan before starting a business
Startup lifeSponsored by

October 14, 2026

‘There's never a right time to start’: Why founders don’t need a master plan before starting a business

‘There's never a right time to start’: Why founders don’t need a master plan before starting a business
Sponsored by OpenPayd
‘Fundraising is uncapped here’: Why Europe’s quantum founders are bullish about building homegrown champions
QuantumAnalysis

October 14, 2026

‘Fundraising is uncapped here’: Why Europe’s quantum founders are bullish about building homegrown champions

By Daphné Leprince-Ringuet

Pro

14 Portuguese fintech startups to watch, according to VCs
FintechInvestor survey

October 14, 2026

14 Portuguese fintech startups to watch, according to VCs

The number of fintech startups in the country has grown more than 10x over the past decade

By Damisola Sulaiman

Pro

The 68 most promising impact startups in Europe, according to investors
Climate techExclusive

October 14, 2026

The 68 most promising impact startups in Europe, according to investors

Jacob Nathan and Doug Kell, the founders of Epoch Biodesign.
By Freya Pratty

Pro

Where Europe's most active pre-seed investors are looking next

October 14, 2026

Where Europe's most active pre-seed investors are looking next

By Oshin Narang

Pro

UK’s first VC fund for refugee founders launches, backed by Atomico

October 14, 2026

UK’s first VC fund for refugee founders launches, backed by Atomico

By Martin Coulter
Nvidia announces billion-dollar investments in European tech

October 13, 2026

Nvidia announces billion-dollar investments in European tech

By Daphné Leprince-Ringuet
‘People just don’t care’: why fintech sovereignty won’t work in Europe
FintechAnalysis

October 13, 2026

‘People just don’t care’: why fintech sovereignty won’t work in Europe

Sifted Summit fintech sovereignty
By Damisola Sulaiman

Pro

Five Luxembourg companies turning traction into growth
Startup lifePaid for and produced by

October 13, 2026

Five Luxembourg companies turning traction into growth

Five Luxembourg companies turning traction into growth
Paid for and produced by Luxinnovation
Inside SF's growing ecosystem for European founders

October 13, 2026

Inside SF's growing ecosystem for European founders

I found an entire ecosystem of investors, accelerators and founder communities geared towards helping Europeans make the move

By Maya Dharampal-Hornby
What will it take for Europe to win in physical AI?

October 13, 2026

What will it take for Europe to win in physical AI?

Physical AI is booming in Europe, but success will be defined by incumbents’ willingness to adopt the technology

By Daphné Leprince-Ringuet

Pro

This ex-Pleo exec plans on taking on US rivals with his ‘AI CFO’ startup
FintechInterview

October 13, 2026

This ex-Pleo exec plans on taking on US rivals with his ‘AI CFO’ startup

Jonathan Sanders Light
By Damisola Sulaiman

Pro

Where the next big companies in Europe could come from, according to US investor

October 13, 2026

Where the next big companies in Europe could come from, according to US investor

Abby Meyers of Bain Capital Ventures
By Anne Sraders

Pro

Stryker to invest $400m in CMR Surgical, with option to buy it outright

October 12, 2026

Stryker to invest $400m in CMR Surgical, with option to buy it outright

By Tom Nugent
Energy unicorn 1Komma5 raises €70m as IPO plans remain on ice

October 12, 2026

Energy unicorn 1Komma5 raises €70m as IPO plans remain on ice

By Martin Coulter
UK government mulls compulsory AI safety reporting

October 12, 2026

UK government mulls compulsory AI safety reporting

AI minister Kanishka Narayan is expected to warn that developers must do more to control increasingly autonomous models

By Martin Coulter
European consumers are begging for better customer support
Artificial intelligencePaid for and produced by

October 12, 2026

European consumers are begging for better customer support

European consumers are begging for better customer support
Paid for and produced by Parloa
Europe’s fastest-growing fintechs are queueing up for growth-stage funding rounds
FundingSifted data

October 12, 2026

Europe’s fastest-growing fintechs are queueing up for growth-stage funding rounds

A picture of Griffin's founders.
By Ruggero Di Spigna

Pro

The ‘biggest threat’ China poses for European startups isn’t what you think
DeeptechInterview

October 12, 2026

The ‘biggest threat’ China poses for European startups isn’t what you think

By Anne Sraders

Pro

Exclusive: Project Europe leads step down as fund readies next chapter

October 12, 2026

Exclusive: Project Europe leads step down as fund readies next chapter

By Martin Coulter

Pro

Scarcity is the mother of European AI invention

October 12, 2026

Scarcity is the mother of European AI invention

Headshot of John Thornhill, Sifted's cofounder and editorial director.
By John Thornhill

Pro